Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Angina Pectoris/MI
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Angina Pectoris/MI
    Updated Guidelines Include Latest Findings on Treatment of MI, Coronary Disease - (DGNews)
    No Significant Benefits to Adding Clopidogrel to Aspirin After Coronary Bypass Surgery: Presented at AHA - (DGDispatch)
    FDA Investigates Risk of Cardiovascular Events in Patients Using Sibutramine - (DGNews)
    Cardiovascular Outcomes Appear Similar for Ezetimibe/Simvastatin and Monotherapy Simvastatin or Atorvastatin: Presented at AHA - (DGDispatch)
    Pretreatment With Enoxaparin, Fondaparinux Improves Survival in Patients With Acute MI Awaiting PCI: Presented at AHA - (DGDispatch)

    News archive

     Recent webcasts/CME - Angina Pectoris/MI
      Keys to Successful Outcomes from Anticoagulant and Antiplatelet Therapy: Addressing Medication Therapy Management Issues
      Cardiovascular Series: Guidelines for Anticoagulant and Antiplatelet Therapy in the Prevention and Treatment of Acute Coronary Syndrome: Incorporation into Clinical Practice
      Translating Evidence-Based Guidelines into Clinical Practice in the Management of Acute Coronary Syndrome
      Advancing the Standard of Care: Cardiovascular and Neurovascular Emergencies
      Anti-inflammatory and Anti-atherogenic Effects of Insulin

      Webcasts/CME archive

       Recent cases - Angina Pectoris/MI
        Dual Antiplatelet Therapy in Coronary Artery Disease: A Case-Based Approach
        Multislice Computed Tomography for Comprehensive Assessment of the Heart in Acute Chest Pain: A Case Report
        Myocardial Ischemia with Left Ventricular Outflow Obstruction
        Cardiovascular Magnetic Resonance of Myocardial Infarction After Blunt Chest Trauma: A Heartbreaking Soccer-Shot
        Spontaneous and Simultaneous Multivessel Coronary Spasm Causing Multisite Myocardial Infarction, Cardiogenic Shock, Atrioventricular Block, and Ventricular Fibrillation

        Cases archive
          




        my personal edition > angina pectoris/mi > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Anaemia A Marker For Higher Mortality Among Elderly With Heart Failure

        A DGReview of :"The prognostic importance of anemia in patients with heart failure."
        American Journal of Medicine

        02/19/2003
        By Harvey McConnell


        Anaemia is associated in older patients with an increased risk of death among those with heart failure, say researchers in the United States.

        What is still not clear, however, is whether the anaemia is a direct cause of worsened outcomes, or if it is a marker for other causal factors, say the investigators at the Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut.

        There is the suggestion in previous studies that anaemia could adversely affect cardiovascular conditions among patients with heart failure, they add, but the prognostic importance of this treatable condition is still not well established.

        The investigators studied a cohort of 2,281 patients, aged 65 and older (mean age 79), who had been admitted to hospital with heart failure. The researchers sought to determine the prognostic value of hematocrit levels. Multivariate Cox proportional hazards regression was used to test whether hematocrit level was an independent predictor of mortality after one year, and readmission of patients to hospital.

        It was found that lower hematocrits were associated with a higher mortality among the cohort. Adjusted for demographic and clinical factors, each 1% lower hematocrit was associated with a 2% greater mortality at one year.

        Compared with patients with a hematocrit over 42%, patients with a hematocrit less than, or equal to, 27%. had a 40% greater one year mortality. This increased risk was similar to that conferred by traditional risk factors, including a left ventricular ejection fraction equal to, or less than, 20%.

        Lower hematocrits were also associated with a greater risk of readmission to hospital.
        Am J Med 2003 Feb;114:2:112-9. "The prognostic importance of anemia in patients with heart failure."

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send